Single-Use Bioreactors Market Trends and Overview

The market size of Single-Use Bioreactors was valued at USD 3.01 billion in 2022. It is projected to reach USD 10.72 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.2% during the forecast period from 2023 to 2030.

Single-Use Bioreactors have emerged as a significant player in the biopharmaceutical industry, offering numerous advantages over traditional stainless-steel bioreactors. These innovative systems provide a flexible and cost-effective solution for bioprocessing, enabling efficient production of various biologics such as vaccines, monoclonal antibodies, and cell therapies.

The increasing demand for biopharmaceuticals, coupled with the need for streamlined manufacturing processes, has fueled the adoption of Single-Use Bioreactors. These bioreactors eliminate the need for time-consuming cleaning and sterilization procedures, reducing downtime and enhancing productivity. Moreover, they offer enhanced scalability, allowing manufacturers to easily adjust production volumes as per market requirements.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/1074

Furthermore, the growing focus on personalized medicine and the rising prevalence of chronic diseases have propelled the demand for biologics, thereby driving the Single-Use Bioreactors market. These bioreactors enable the production of smaller batches of biopharmaceuticals, facilitating personalized treatments and reducing the risk of contamination.

Geographically, North America holds a significant share in the Single-Use Bioreactors market, owing to the presence of a well-established biopharmaceutical industry and favorable government initiatives. Additionally, the Asia Pacific region is expected to witness substantial growth during the forecast period, attributed to the increasing investments in biopharmaceutical research and development, along with the rising adoption of advanced bioprocessing technologies.

KEY MARKET SEGMENTATION:

By Product

• Single-use Bioreactor Systems
• Single-use Filtration Assemblies
• Single-use Media Bags
• Other

By Type

• Stirred-tank SUBs
• Bubble-column SUBs
• Wave-induced SUBs
• Other

By type of cell

• Mammalian Cells
• Yeast Cells
• Bacterial Cells
• Other Cells (Insect and plant cells)

By Molecule Type

• Monoclonal Antibodies
• Gene-modified cells
• Vaccines
• Stem Cells
• Other

By Application

• Research and Development (R&D)
• Bioproduction
• Process Development

By End User

• Pharmaceutical & Biopharmaceutical Companies
• Academic & Research Institutes
• CROs & CMOs

Major Players Listed in the Report are as Follows:

Thermo Fisher Scientific, Danaher, Sartorius Stedim Biotech, Merck KgaA, Getinge AB, Celltainer Biotech BV, Eppendorf AG, PBS Biotech Inc., Solida Biotech GmbH, Cellexus, Distek Inc., Able Corporation & Biott Corporation, ABEC, G&G Technologies Inc., Satake Chemical Equipment Mfg Ltd., bbi-biotech GmbH, Stobbe Pharma GmbH and Other Players.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com